Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000687708 | SCV000815293 | pathogenic | DPAGT1-congenital disorder of glycosylation; Congenital myasthenic syndrome 13 | 2023-12-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Met9Ilefs*80) in the DPAGT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DPAGT1 are known to be pathogenic (PMID: 22742743). This variant is present in population databases (rs768656482, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with DPAGT1-related conditions (PMID: 30117111). ClinVar contains an entry for this variant (Variation ID: 567578). For these reasons, this variant has been classified as Pathogenic. |
University of Washington Center for Mendelian Genomics, |
RCV001291076 | SCV001479439 | likely pathogenic | Congenital disorder of glycosylation | no assertion criteria provided | research |